Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 11.91% is 72% above its 5-year average of 6.91%, near the high end of its 5-year range (3.63%–11.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 18.35% above its 12-month average of 10.06%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): 11.91%.
RETURN ON INVESTED CAPITAL (ROIC)
11.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
10.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
6.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
6.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
9.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
10.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
10.64%
CURRENT VS TTM AVG
+18.35%
CURRENT VS 3Y AVG
+80.09%
CURRENT VS 5Y AVG
+72.36%
CURRENT VS 10Y AVG
+28.39%
CURRENT VS 15Y AVG
+11.89%
CURRENT VS 20Y AVG
+11.89%
SECTOR MEDIAN · HEALTHCARE
-35.63%
median of 823 covered companies
CURRENT VS SECTOR MEDIAN
+133.42%
vs the sector median at left
Phibro Animal Health Corporation
Market Cap
$1.49B
Return on Invested Capital (ROIC)
11.91%
TTM Avg
10.06%
3Y Avg
6.61%
5Y Avg
6.91%
Market Cap
$1.49B
Return on Invested Capital (ROIC)
20.41%
TTM Avg
-2.25%
3Y Avg
-13.09%
5Y Avg
-29.56%
Market Cap
$1.46B
Return on Invested Capital (ROIC)
-19.87%
TTM Avg
-24.87%
3Y Avg
-20.19%
5Y Avg
-15.68%
Market Cap
$1.46B
Return on Invested Capital (ROIC)
-35.66%
TTM Avg
-26.24%
3Y Avg
-27.95%
5Y Avg
-27.95%
Market Cap
$1.45B
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.53B
Return on Invested Capital (ROIC)
33.76%
TTM Avg
23.76%
3Y Avg
-16.29%
5Y Avg
5.45%
Market Cap
$1.44B
Return on Invested Capital (ROIC)
16.83%
TTM Avg
6.43%
3Y Avg
6.32%
5Y Avg
5.53%
Market Cap
$1.53B
Return on Invested Capital (ROIC)
-22.55%
TTM Avg
-30.11%
3Y Avg
-30.00%
5Y Avg
-19.97%
Market Cap
$1.53B
Return on Invested Capital (ROIC)
-63.12%
TTM Avg
-24.75%
3Y Avg
-38.52%
5Y Avg
-35.23%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phibro Animal Health Corporation (PAHC) | $1.49B | 11.91% | 10.06% | 6.61% | 6.91% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.49B | 20.41% | -2.25% | -13.09% | -29.56% |
| GH Research PLC (GHRS)vs › | $1.46B | -19.87% | -24.87% | -20.19% | -15.68% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.46B | -35.66% | -26.24% | -27.95% | -27.95% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 33.76% | 23.76% | -16.29% | 5.45% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.44B | 16.83% | 6.43% | 6.32% | 5.53% |
| uniQure N.V. (QURE)vs › | $1.53B | -22.55% | -30.11% | -30.00% | -19.97% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.53B | -63.12% | -24.75% | -38.52% | -35.23% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -32.15% | -60.15% | -48.54% | -35.53% |
ROIC
11.9%
ROE
25.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 11.91% |
| 2026-03-31 | 11.47% |
| 2025-12-31 | 10.81% |
| 2025-09-30 | 8.89% |
| 2025-06-30 | 7.24% |
| 2025-03-31 | 5.61% |
| 2024-12-31 | 4.36% |
| 2024-09-30 | 4.95% |
| 2024-06-30 | 3.63% |
| 2024-03-31 | 3.94% |
| 2023-12-31 | 3.89% |
| 2023-09-30 | 3.98% |
| 2023-06-30 | 5.30% |
| 2023-03-31 | 5.53% |
| 2022-12-31 | 5.65% |
| 2022-09-30 | 6.73% |
| 2022-06-30 | 7.10% |
| 2022-03-31 | 7.82% |
| 2021-12-31 | 8.71% |
| 2021-09-30 | 8.67% |
| 2021-06-30 | 8.92% |
| 2021-03-31 | 7.20% |
| 2020-12-31 | 7.45% |
| 2020-09-30 | 7.29% |
| 2020-06-30 | 6.48% |
| 2020-03-31 | 7.59% |
| 2019-12-31 | 7.59% |
| 2019-09-30 | 8.26% |
| 2019-06-30 | 10.89% |
| 2019-03-31 | 13.14% |
| 2018-12-31 | 14.19% |
| 2018-09-30 | 12.57% |
| 2018-06-30 | 13.47% |
| 2018-03-31 | 12.39% |
| 2017-12-31 | 13.53% |
| 2017-09-30 | 14.73% |
| 2017-06-30 | 15.30% |
| 2017-03-31 | 15.01% |
| 2016-12-31 | 13.98% |
| 2016-09-30 | 17.15% |
| 2016-06-30 | 17.00% |
| 2016-03-31 | 17.08% |
| 2015-12-31 | 19.95% |
| 2015-09-30 | 16.04% |
| 2015-06-30 | 17.44% |
| 2015-03-31 | 17.38% |
| 2014-12-31 | 15.57% |
| 2014-09-30 | 10.87% |
| 2014-06-30 | 9.68% |
| 2014-03-31 | 14.03% |
| 2013-12-31 | 13.72% |
| 2013-09-30 | 16.13% |
| 2013-06-30 | 15.94% |
| 2006-03-31 | 10.79% |
| 2005-12-31 | 7.23% |
| 2005-09-30 | 2.76% |
| 2005-06-30 | 4.03% |
| 2005-03-31 | 4.66% |
| 2004-12-31 | 7.55% |
| 2004-09-30 | 18.49% |
| 2004-06-30 | 19.27% |
| 2004-03-31 | 15.74% |
| 2003-12-31 | 16.74% |
| 2003-09-30 | 9.54% |
| 2003-06-30 | 9.59% |
